Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Antiviral Research

• Publication date

  2014-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.antiviral.2014.03.015PMID 24747042
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Low‐dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation

  2013cited by this paper
• Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey.

  2013cited by this paper
• Acyclovir-resistant herpes simplex virus type 1 in intra-ocular fluid samples of herpetic uveitis patients.

  2013cited by this paper
• Risk of second primary melanoma: how long should follow‐up be? Ratio of observed and expected cases

  2012cited by this paper
• Effects of mutations on herpes simplex virus 1 thymidine kinase functionality: an in vitro assay based on detection of monophosphate forms of acyclovir and thymidine using HPLC/DAD.

  2012cited by this paper
• Patients’ profile, burden of disease and quality of life in recurrent herpes labialis: a survey conducted in USA and France

  2012cited by this paper
• Public awareness and knowledge of herpes labialis

  2012cited by this paper
• Latent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals.

  2012cited by this paper
• Significance of amino acid substitutions in the thymidine kinase gene of herpes simplex virus type 1 for resistance.

  2012cited by this paper
• Longitudinal Characterization of Herpes Simplex Virus (HSV) Isolates Acquired From Different Sites in an Immune-Compromised Child: A New HSV Thymidine Kinase Mutation Associated With Resistance.

  2012cited by this paper
• Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity.

  2012cited by this paper
• Viral loads and antiviral resistance of herpesviruses and oral ulcerations in hematopoietic stem cell transplant recipients

  2012cited by this paper
• Novel Resistance-Associated Mutations of Thymidine Kinase and Dna Polymerase Genes of Herpes Simplex Virus Type 1 and Type 2

  2011cited by this paper
• Gene Polymorphism of Thymidine Kinase and Dna Polymerase in Clinical Strains of Herpes Simplex Virus

  2011cited by this paper
• Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus.

  2010cited by this paper
• Genotypic Characterization of UL23 Thymidine Kinase and UL30 DNA Polymerase of Clinical Isolates of Herpes Simplex Virus: Natural Polymorphism and Mutations Associated with Resistance to Antivirals

  2010cited by this paper
• Genotypic detection of acyclovir-resistant HSV-1: characterization of 67 ACV-sensitive and 14 ACV-resistant viruses.

  2008cited by this paper
• DNA Polymerase Mutations in Drug-Resistant Herpes Simplex Virus Mutants Determine In Vivo Neurovirulence and Drug-Enzyme Interactions

  2007cited by this paper
• Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons

  2007cited by this paper
• Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO).

  2006cited by this paper
• Thymidine Kinase Mutations Conferring Acyclovir Resistance in Herpes Simplex Type 1 Recombinant Viruses

  2006cited by this paper
• Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1.

  2006cited by this paper
• Characterization of Herpes Simplex Virus Type 1 Thymidine Kinase Mutants Selected under a Single Round of High-Dose Brivudin

  2005cited by this paper
• Development of herpes simplex virus disease in patients who are receiving cidofovir.

  2005cited by this paper
• Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus.

  2004cited by this paper
• Surveillance Network for Herpes Simplex Virus Resistance to Antiviral Drugs: 3-Year Follow-Up

  2004cited by this paper
• [Antiviral sensitivity of herpes simplex virus in immunocompromised patients].

  2004cited by this paper
• Management of acyclovir-resistant herpes simplex virus.

  2003cited by this paper
• Herpes simplex virus resistance to antiviral drugs.

  2003cited by this paper
• Drug Resistance Patterns of Recombinant Herpes Simplex Virus DNA Polymerase Mutants Generated with a Set of Overlapping Cosmids and Plasmids

  2003cited by this paper
• Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain.

  2002cited by this paper
• Characterization of Herpes Simplex Viruses Selected in Culture for Resistance to Penciclovir or Acyclovir

  2001cited by this paper
• Highly Reliable Heterologous System for Evaluating Resistance of Clinical Herpes Simplex Virus Isolates to Nucleoside Analogues

  2001cited by this paper
• Virological diagnosis of herpes simplex encephalitis.

  2000cited by this paper
• Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations—relevance for the incidence of genital herpes

  2000cited by this paper
• Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.

  1999cited by this paper
• Substrate Diversity of Herpes Simplex Virus Thymidine Kinase

  1999cited by this paper
• Typing and strain differentiation of clinical herpes simplex virus type 1 and 2 isolates by polymerase chain reaction and subsequent restriction fragment length polymorphism analysis.

  1994cited by this paper
• Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.

  1994cited by this paper
• Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir

  1993cited by this paper
• The structure and function of the HSV DNA replication proteins: defining novel antiviral targets.

  1993cited by this paper
• Resistance to antiviral inhibitors caused by the mutation S889A in the highly-conserved 885-GDTDS motif of the herpes simplex virus type 1 DNA polymerase.

  1993cited by this paper
• A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance

  1992cited by this paper
• A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.

  1991cited by this paper
• Herpesviral deoxythymidine kinases contain a site analogous to the phosphoryl-binding arginine-rich region of porcine adenylate kinase; comparison of secondary structure predictions and conservation.

  1990cited by this paper
• Herpes simplex virus resistant to acyclovir. A study in a tertiary care center.

  1990cited by this paper
• Herpes Simplex Virus Resistant to Acyclovir: A Study in a Tertiary Care Center

  1990cited by this paper
• In vitro mutagenesis of the herpes simplex virus type 1 DNA polymerase gene results in altered drug sensitivity of the enzyme

  1989cited by this paper
• Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?

  1989cited by this paper
• Related functional domains in virus DNA polymerases.

  1987cited by this paper
• Evidence that the 'active centre' of the herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide.

  1986cited by this paper
• Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1.

  1985cited by this paper
• Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities.

  1985cited by this paper
• Utilization of internal AUG codons for initiation of protein synthesis directed by mRNAs from normal and mutant genes encoding herpes simplex virus-specified thymidine kinase

  1985cited by this paper
• Infection with herpes simplex virus and cell-mediated immunity after marrow transplant.

  1980cited by this paper

• Predicting the Impact of Drug Resistance Mutations on Inhibitor Potency with Molecular Dynamics and Machine Learning.

  2025cites this paper
• Dimeric Bisbenzimidazole DB2A(7) Protects Mice From Lethal Genital Herpes and Herpetic Skin Lesions

  2025cites this paper
• Reactivation of Multidrug-Resistant HSV-1 in a Post–Allogenic Hematopoietic Stem Cell Transplant Patient: Dynamic Detection of the Rare A605V Mutation by Next-Generation Sequencing

  2024cites this paper
• Viral DNA polymerase structures reveal mechanisms of antiviral drug resistance.

  2024cites this paper
• Novel UL23 and UL30 substitutions in HSV1 and HSV2 viruses related to polymorphism or drug resistance.

  2023cites this paper
• Acyclovir‐resistant HSV‐1 isolates among immunocompromised patients in southern Taiwan: Low prevalence and novel mutations

  2023cites this paper
• Non-cytopathic herpes simplex virus type-1 isolated from acyclovir-treated patients with recurrent infections

  2022cites this paper
• Non-cytopathic herpes simplex virus type-1 isolated from acyclovir-treated patients with recurrent infections

  2022cites this paper
• Cell and Tissue Specific Metabolism of Nucleoside and Nucleotide Drugs: Case Studies and Implications for Precision Medicine

  2022cites this paper
• Acyclovir-resistant HSV-1 keratitis: a concerning and emerging clinical challenge.

  2022cites this paper
• DNA polymerases of herpesviruses and their inhibitors.

  2021cites this paper
• Antiviral susceptibility of recombinant herpes simplex virus 1 strains with specific polymerase amino acid changes.

  2021cites this paper
• Drug Resistance in Skin Diseases

  2021cites this paper
• Phenotypic and Genotypic Testing of HSV-1 and HSV-2 Resistance to Antivirals.

  2020cites this paper
• A Plasmid-Expressed CRISPR/Cas9 System Suppresses Replication of HSV Type I in a Vero Cell Culture

  2019cites this paper
• [A Plasmid-Expressed CRISPR/Cas9 System Suppresses Replication of HSV Type I in a Vero Cell Culture].

  2019cites this paper
• Infection and Drug Resistance Dovepress

  2019cites this paper
• Mechanism of resistance to acyclovir in thymidine kinase mutants from Herpes simplex virus type 1: a computational approach

  2019influential citation
• Herpes simplex virus resistant to acyclovir: a single centre experience from the Czech Republic.

  2019cites this paper
• Alpha-Herpesvirus Thymidine Kinase Genes Mediate Viral Virulence and Are Potential Therapeutic Targets

  2019cites this paper
• Relevance of non‐synonymous thymidine kinase mutations for antiviral resistance of recombinant herpes simplex virus type 2 strains

  2018cites this paper
• The Anti–Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase

  2018cites this paper
• Evaluation of Oncolytic and Immunomodulatory Potential of the HSV-1 Live-Attenuated Vaccine Strain VC2 in an Immunocompetent Murine Melanoma Model

  2018cites this paper
• Entry inhibition of HSV‐1 and ‐2 protects mice from viral lethal challenge

  2017cites this paper
• Stepwise characterization of non-synonymous mutations in the HSV-1 thymidine kinase gene by different functional assays.

  2017cites this paper
• Recombinant herpes simplex virus type 1 strains with targeted mutations relevant for aciclovir susceptibility

  2016cites this paper
• Optimal management of genital herpes: current perspectives

  2016cites this paper
• Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymerase

  2016cites this paper
• Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes of herpes simplex virus types 1 and 2.

  2016cites this paper
• Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections

  2016cites this paper
• Features of HSV Infection in Immunocompromised Patients Disease spectrum

  2016cites this paper
• De Novo Assembly of Human Herpes Virus Type 1 (HHV-1) Genome, Mining of Non-Canonical Structures and Detection of Novel Drug-Resistance Mutations Using Short- and Long-Read Next Generation Sequencing Technologies

  2016cites this paper
• Aciclovir resistance phenotype of clinical isolates proven by targeted mutagenesis of recombinant herpes simplex and varicella zoster viruses

  2016cites this paper
• Synthetic α-Hydroxytropolones Inhibit Replication of Wild-Type and Acyclovir-Resistant Herpes Simplex Viruses

  2016cites this paper
• Herpes Simplex Virus and Varicella-Zoster Virus

  2016cites this paper
• Varicella-zoster virus infections – antiviral therapy and diagnosis

  2016cites this paper
• Desenvolvimento de métodos de diagnóstico, silenciamento gênico e caracterização molecular do vírus herpes simples tipo 1 e herpesvírus humano tipo 6 em pacientes imunocomprometidos do Rio de Janeiro

  2015influential citation
• Novel method for genotyping clinical herpes simplex virus type 1 isolates

  2015cites this paper
• Sequence Analysis of Herpes Simplex Virus 1 Thymidine Kinase and DNA Polymerase Genes from over 300 Clinical Isolates from 1973 to 2014 Finds Novel Mutations That May Be Relevant for Development of Antiviral Resistance

  2015influential citation
• Resistance testing of clinical herpes simplex virus type 2 isolates collected over 4 decades.

  2015cites this paper
• Helicase‐Primase as a Target of New Therapies for Herpes Simplex Virus Infections

  2015cites this paper
• Designing herpes viruses as oncolytics

  2015cites this paper
• Synthesis and antiviral activity of 1-(1,3-disubstitutedimidazolidyn-2-ylidene)-3-ethoxycarbonylmethylurea derivatives

  2015cites this paper
• Genotypic Characterization of Herpes Simplex Virus Type 1 Isolates in Immunocompromised Patients in Rio de Janeiro, Brazil

  2015influential citation
• Drug Resistance of Clinical Varicella-Zoster Virus Strains Confirmed by Recombinant Thymidine Kinase Expression and by Targeted Resistance Mutagenesis of a Cloned Wild-Type Isolate

  2015cites this paper
• Erratum to: Novel method for genotyping clinical herpes simplex virus type 1 isolates

  2015cites this paper
• Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance.

  2014cites this paper
• Zakażenie wirusem cytomegalii u młodzieży jako czynnik ryzyka rozwoju przedklinicznej postaci miażdżycy

  2014cites this paper